查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1987015

医疗保健领域人工智慧 (AI) 市场到 2035 年的分析和预测：按类型、产品类型、技术、组件、应用、部署模式、最终用户、解决方案和交付模式划分。

Artificial Intelligence in Healthcare Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Deployment, End User, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球医疗保健领域的人工智慧 (AI) 市场预计将从 2025 年的 146 亿美元成长到 2035 年的 1,027 亿美元，复合年增长率 (CAGR) 为 21.8%。这一增长主要得益于机器学习技术的进步、医疗数据量的不断增长、对个人化医疗的需求以及人工智慧在简化诊断和患者照护方面发挥的作用。医疗保健领域的人工智慧市场由几个关键细分市场构成，其中机器学习约占 35% 的市场份额，其次是自然语言处理（25%）和机器人流程自动化 (RPA)（20%）。主要应用包括诊断、个人化医疗和医院管理系统。该市场集中度适中，由少数主要企业和众多中小企业组成，形成了一个多元化的生态系统。实施数据分析表明，在人工智慧驱动的诊断工具和患者管理系统日益普及的推动下，医疗机构中人工智慧的部署数量正在不断增加。

竞争格局由全球性和区域性公司共同构成，其中科技巨头和医疗人工智慧专家扮演着重要角色。人工智慧演算法的不断进步及其与现有医疗系统的融合推动了创新水准的显着提高。为拓展技术能力和市场覆盖面，併购和策略联盟屡见不鲜。一个值得关注的趋势是，科技公司与医疗服务提供者携手合作，共同开发人工智慧驱动的解决方案，以改善患者预后并提升营运效率。

市场区隔
类型 机器学习、自然语言处理、电脑视觉、机器人技术及其他
产品 基于人工智慧的软体、基于人工智慧的硬体、基于人工智慧的服务等等。
科技 深度学习、预测分析、语音辨识、影像识别等等。
成分 软体、硬体、服务及其他
目的 临床试验、机器人辅助手术、虚拟护理助理、行政工作流程支援、诈欺检测、诊断和治疗、病患管理等。
实作方法 云端部署、本地部署、混合部署及其他
最终用户 医院、製药公司、研究机构、医疗保健提供者及其他
解决方案 患者数据和风险分析、医学影像和诊断、生活方式管理和监测、虚拟助理等。
提供的表格 B2B、B2C、其他

医疗保健领域人工智慧市场的「类型」细分市场主要受机器学习和自然语言处理技术日益普及的驱动。机器学习因其能够分析复杂资料集并提高诊断准确率而成为主流。另一方面，自然语言处理对于管理临床记录中的非结构化资料至关重要。这些技术对于改善患者照护和营运效率至关重要，医院和研究机构对利用人工智慧进行预测分析和个人化医疗的需求十分旺盛。

在技​​术领域，深度学习和电脑视觉处于领先地位，这主要得益于其在医学影像和诊断领域的应用。深度学习演算法擅长模式识别，能够更准确地解读医学影像，这在放射学和病理学中至关重要。电脑视觉也越来越多地应用于外科手术辅助和病患生命征象监测。人工智慧演算法的不断进步以及人工智慧与物联网设备的整合正在推动其发展，尤其是在拥有完善医疗基础设施的发达地区。

在应用领域，诊断和个人化医疗方面取得了显着进展。诊断是人工智慧应用的一个重要分支，人工智慧提高了疾病检测的速度和准确性，尤其是在肿瘤学和心臟病学领域。个人化医疗正蓬勃发展，这得益于人工智慧能够根据个人基因谱优化治疗方法。这种需求源于对精准医疗解决方案的需求以及对预防医学日益增长的重视，而病患资料的可用性提高和先进分析工具的普及也为此提供了支持。

在终端用户领域，医院和医疗机构是人工智慧应用的主要推动者。医院利用人工智慧透过增强决策能力和自动化工作流程来改善病患预后、简化营运流程并降低成本。医疗机构则利用人工智慧进行病患管理和治疗方案。医疗保健产业数位转型趋势以及提供以价值为导向的医疗服务的压力，正促使这些终端用户对人工智慧技术进行大量投资。

组件领域以软体解决方案为主，这些解决方案构成了医疗保健领域人工智慧应用的基础。人工智慧软体平台对于资料管理、演算法开发以及在临床环境中部署人工智慧模型至关重要。 GPU 和处理器等硬体组件对于满足人工智慧系统的运算需求也至关重要。随着人工智慧模型日益复杂，即时数据处理的需求不断增长，对软体和硬体的投资都在推动市场需求，而具有可扩展性和柔软性的云端解决方案也越来越受欢迎。

区域概览

北美：北美医疗保健领域的人工智慧市场高度成熟，这得益于其强大的技术基础设施和大量的研发投入。美国在该地区处于领先地位，尤其专注于精准医疗和数位健康解决方案。生物技术、製药和医疗设备等关键产业正在加速人工智慧的整合，以改善病患疗效和提升营运效率。

欧洲：欧洲市场发展较成熟，英国、德国和法国等国在医疗保健领域引领人工智慧的应用。该地区受益于完善的法规结构和对数位化医疗转型的高度重视。推动需求的关键产业包括医疗保健IT、诊断和远端医疗，这些产业正利用人工智慧技术来改善医疗服务和患者照护。

亚太地区：人工智慧医疗应用在亚太地区正快速发展，中国、日本和印度等国家处于领先地位。该市场的特点是对人工智慧Start-Ups的投资不断增加，以及政府主导的旨在加强医疗基础设施的各项倡议。关键产业包括医院管理、诊断和穿戴式技术，人工智慧正被用于应对庞大人口和多样化医疗需求带来​​的挑战。

拉丁美洲：拉丁美洲的医疗人工智慧市场仍处于起步阶段，巴西和墨西哥贡献显着。人工智慧技术正逐步引入该地区，以提高医疗服务的可及性和效率。关键产业包括远距远端医疗、医疗资讯科技和诊断。这是因为人工智慧解决方案正被部署用于克服区域医疗资源不平衡和资源限制等问题。

中东和非洲：中东和非洲地区正在崛起为领先的人工智慧医疗市场，其中阿联酋和南非处于领先地位。政府主导的医疗创新措施和投资是推动该市场发展的主要动力。关键产业包括医院管理和远端医疗，人工智慧正被应用于这些领域，以改善偏远地区的医疗服务并提高整个系统的效率。

主要趋势和驱动因素

趋势一：人工智慧在诊断影像的应用

人工智慧在诊断影像领域的应用正在革新医疗产业，显着提升医学影像的准确性和效率。人工智慧演算法正被越来越多地用于分析复杂的影像数据，从而实现对癌症、心血管疾病和神经系统疾病等病症更快、更准确的诊断。这一趋势的驱动力源于对更先进诊断工具的需求、影像检查数量的不断增长以及减少放射学中人为错误的迫切需求。

两大趋势：个人化医疗和人工智慧

人工智慧在推进个人化医疗方面发挥着至关重要的作用，它能够分析大规模数据集，识别模式并预测个体对治疗的反应。这一趋势的驱动力源于基因组数据的日益丰富以及对个人化治疗方案的需求，这些方案需充分考虑个体的基因组成、生活方式和环境因素。人工智慧驱动的个人化医疗可望透过改善患者疗效、减少药物副作用和优化治疗方案，彻底改变医疗保健的提供方式。

三大趋势：人工智慧驱动的虚拟健康助理

人工智慧驱动的虚拟健康助理正日益普及，使患者能够全天候获取医疗资讯和支援。这些数位助理利用自然语言处理和机器学习技术，提供个人化的健康建议、安排预约并管理慢性疾病。这一趋势的驱动力源于人们对便利、经济的医疗保健解决方案日益增长的需求，以及远距远端医疗和远端患者监护技术的广泛应用。

四大趋势：人工智慧医疗应用监管的演变

监管机构日益认识到人工智慧在医疗保健领域的潜力，并致力于建立相关框架，以确保人工智慧技术的安全有效应用。这一趋势包括制定人工智慧应用指南和标准，以应对资料隐私、演算法透明度和患者安全等挑战。监管方面的进展对于促进创新至关重要，同时也能确保人工智慧解决方案符合严格的医疗保健标准并且广泛应用。

五大趋势：人工智慧在药物发现与研发的应用

人工智慧正在变革药物发现和开发流程，显着缩短新药上市的时间并降低成本。机器学习演算法正被用于识别有前景的候选药物、预测其疗效并优化临床试验设计。这一趋势的驱动力源自于製药业加速研发进程和提高成功率的需求。人工智慧分析大量资料集并从中产生洞见的能力，已被证明在寻找新型疗法和个人化治疗方法方面具有不可估量的价值。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制因素
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章：细分市场分析

  • 市场规模及预测：依类型
    • 机器学习
    • 自然语言处理
    • 电脑视觉
    • 机器人技术
    • 其他的
  • 市场规模及预测：依产品划分
    • 基于人工智慧的软体
    • 人工智慧驱动的硬体
    • 基于人工智慧的服务
    • 其他的
  • 市场规模及预测：依技术划分
    • 深度学习
    • 预测分析
    • 语音辨识
    • 影像识别
    • 其他的
  • 市场规模及预测：依组件划分
    • 软体
    • 硬体
    • 服务
    • 其他的
  • 市场规模及预测：依应用领域划分
    • 临床试验
    • 机器人辅助手术
    • 虚拟护理助理
    • 支援行政工作流程
    • 诈欺侦测
    • 诊断和治疗
    • 病患管理
    • 其他的
  • 市场规模及预测：依最终用户划分
    • 医院
    • 製药公司
    • 研究所
    • 医疗保健提供者
    • 其他的
  • 市场规模及预测：依市场细分
    • 基于云端的
    • 现场
    • 杂交种
    • 其他的
  • 市场规模及预测：按解决方案划分
    • 患者数据和风险分析
    • 医学影像诊断
    • 生活方式管理和监测
    • 虚拟助手
    • 其他的
  • 市场规模及预测：以交付方式划分
    • B2B
    • B2C
    • 其他的

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 供需差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 监管概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • IBM
  • Microsoft
  • Google
  • Amazon
  • Siemens Healthineers
  • Philips Healthcare
  • GE Healthcare
  • Medtronic
  • Cerner Corporation
  • Epic Systems Corporation
  • NVIDIA
  • Intel Corporation
  • Nuance Communications
  • Allscripts Healthcare Solutions
  • Zebra Medical Vision
  • iCarbonX
  • Tempus Labs
  • PathAI
  • Butterfly Network
  • Viz.ai

第九章 关于我们

简介目录
Product Code: GIS20011

The global Artificial Intelligence in Healthcare Market is projected to grow from $14.6 billion in 2025 to $102.7 billion by 2035, at a compound annual growth rate (CAGR) of 21.8%. Growth is driven by advancements in machine learning, increasing healthcare data, personalized medicine demand, and AI's role in diagnostics and patient care efficiency. The Artificial Intelligence in Healthcare Market is characterized by several leading segments, with machine learning holding approximately 35% market share, followed by natural language processing at 25%, and robotic process automation at 20%. Key applications include diagnostics, personalized medicine, and hospital management systems. The market is moderately consolidated, with a few dominant players and numerous smaller firms contributing to a diverse ecosystem. Volume insights indicate a growing number of AI installations in healthcare facilities, driven by the increasing adoption of AI-powered diagnostic tools and patient management systems.

The competitive landscape features a mix of global and regional players, with significant contributions from technology giants and specialized healthcare AI firms. The degree of innovation is high, with continuous advancements in AI algorithms and integration with existing healthcare systems. Mergers and acquisitions, along with strategic partnerships, are prevalent as companies seek to expand their technological capabilities and market reach. Notable trends include collaborations between tech companies and healthcare providers to develop AI-driven solutions that enhance patient outcomes and operational efficiency.

Market Segmentation
TypeMachine Learning, Natural Language Processing, Computer Vision, Robotics, Others
ProductAI-based Software, AI-based Hardware, AI-based Services, Others
TechnologyDeep Learning, Predictive Analytics, Speech Recognition, Image Recognition, Others
ComponentSoftware, Hardware, Services, Others
ApplicationClinical Trials, Robot-Assisted Surgery, Virtual Nursing Assistants, Administrative Workflow Assistance, Fraud Detection, Diagnosis and Treatment, Patient Management, Others
DeploymentCloud-Based, On-Premises, Hybrid, Others
End UserHospitals, Pharmaceutical Companies, Research Laboratories, Healthcare Providers, Others
SolutionsPatient Data & Risk Analytics, Medical Imaging & Diagnostics, Lifestyle Management & Monitoring, Virtual Assistants, Others
ModeB2B, B2C, Others

The Type segment in the AI in Healthcare market is primarily driven by the increasing adoption of machine learning and natural language processing technologies. Machine learning dominates due to its ability to analyze complex datasets and improve diagnostic accuracy, while natural language processing is crucial for managing unstructured data in clinical documentation. These technologies are pivotal in enhancing patient care and operational efficiency, with significant demand from hospitals and research institutions seeking to leverage AI for predictive analytics and personalized medicine.

In the Technology segment, deep learning and computer vision are at the forefront, driven by their applications in medical imaging and diagnostics. Deep learning algorithms excel in pattern recognition, enabling more accurate interpretation of medical images, which is critical in radiology and pathology. Computer vision is increasingly used for surgical assistance and monitoring patient vitals. The ongoing advancements in AI algorithms and the integration of AI with IoT devices are propelling growth, particularly in developed regions with advanced healthcare infrastructure.

The Application segment sees significant traction in the areas of diagnostics and personalized medicine. Diagnostics is the leading subsegment, as AI enhances the speed and accuracy of disease detection, particularly in oncology and cardiology. Personalized medicine is gaining momentum with AI's ability to tailor treatments based on individual genetic profiles. The demand is driven by the need for precision healthcare solutions and the growing emphasis on preventive care, supported by the increasing availability of patient data and advanced analytics tools.

Within the End User segment, hospitals and healthcare providers are the primary drivers of AI adoption. Hospitals leverage AI to improve patient outcomes, streamline operations, and reduce costs through enhanced decision-making and workflow automation. Healthcare providers use AI for patient management and treatment planning. The trend towards digital transformation in healthcare, coupled with the pressure to deliver value-based care, is encouraging these end users to invest heavily in AI technologies.

The Component segment is dominated by software solutions, which form the backbone of AI applications in healthcare. AI software platforms are essential for data management, algorithm development, and deployment of AI models in clinical settings. Hardware components, such as GPUs and processors, are also critical, supporting the computational needs of AI systems. The increasing complexity of AI models and the need for real-time data processing are driving investments in both software and hardware, with cloud-based solutions gaining popularity for their scalability and flexibility.

Geographical Overview

North America: The North American AI in healthcare market is highly mature, driven by robust technological infrastructure and significant investment in R&D. The United States leads the region, with a strong focus on precision medicine and digital health solutions. Key industries include biotechnology, pharmaceuticals, and medical devices, which are increasingly integrating AI to enhance patient outcomes and operational efficiency.

Europe: Europe exhibits moderate market maturity, with countries like the UK, Germany, and France spearheading AI adoption in healthcare. The region benefits from supportive regulatory frameworks and a focus on digital health transformation. Key industries driving demand include healthcare IT, diagnostics, and telemedicine, as AI technologies are leveraged to improve healthcare delivery and patient care.

Asia-Pacific: The Asia-Pacific region is experiencing rapid growth in AI healthcare applications, with countries like China, Japan, and India leading the charge. The market is characterized by increasing investments in AI startups and government initiatives to enhance healthcare infrastructure. Key industries include hospital management, diagnostics, and wearable technology, as AI is utilized to address the challenges of large populations and diverse healthcare needs.

Latin America: The Latin American AI in healthcare market is in the nascent stage, with Brazil and Mexico being notable contributors. The region is gradually adopting AI technologies to improve healthcare accessibility and efficiency. Key industries include telemedicine, healthcare IT, and diagnostics, as AI solutions are implemented to overcome regional healthcare disparities and resource constraints.

Middle East & Africa: The Middle East & Africa region is emerging in the AI healthcare market, with the UAE and South Africa at the forefront. The market is driven by government initiatives and investments in healthcare innovation. Key industries include hospital management and telemedicine, as AI is deployed to enhance healthcare delivery in remote areas and improve overall system efficiency.

Key Trends and Drivers

Trend 1 Title: Integration of AI in Diagnostic Imaging

The integration of artificial intelligence in diagnostic imaging is revolutionizing the healthcare industry by enhancing the accuracy and efficiency of medical imaging. AI algorithms are increasingly being used to analyze complex imaging data, enabling faster and more precise diagnosis of conditions such as cancer, cardiovascular diseases, and neurological disorders. This trend is driven by the need for improved diagnostic tools, the growing volume of imaging procedures, and the demand for reducing human error in radiology.

Trend 2 Title: Personalized Medicine and AI

AI is playing a crucial role in advancing personalized medicine by enabling the analysis of large datasets to identify patterns and predict individual responses to treatments. This trend is fueled by the increasing availability of genomic data and the need for tailored therapeutic approaches that consider an individual's genetic makeup, lifestyle, and environment. AI-driven personalized medicine is expected to improve patient outcomes, reduce adverse drug reactions, and optimize treatment plans, thereby transforming healthcare delivery.

Trend 3 Title: AI-Powered Virtual Health Assistants

The adoption of AI-powered virtual health assistants is on the rise, providing patients with 24/7 access to healthcare information and support. These digital assistants leverage natural language processing and machine learning to offer personalized health advice, schedule appointments, and manage chronic conditions. This trend is driven by the growing demand for convenient and cost-effective healthcare solutions, as well as the increasing use of telemedicine and remote patient monitoring technologies.

Trend 4 Title: Regulatory Advancements in AI Healthcare Applications

Regulatory bodies are increasingly recognizing the potential of AI in healthcare and are working towards creating frameworks that ensure the safe and effective use of AI technologies. This trend involves the development of guidelines and standards for AI applications, addressing issues such as data privacy, algorithm transparency, and patient safety. Regulatory advancements are crucial for fostering innovation while ensuring that AI solutions meet stringent healthcare standards and gain widespread adoption.

Trend 5 Title: AI in Drug Discovery and Development

AI is transforming the drug discovery and development process by significantly reducing the time and cost associated with bringing new drugs to market. Machine learning algorithms are being used to identify potential drug candidates, predict their efficacy, and optimize clinical trial designs. This trend is driven by the pharmaceutical industry's need to accelerate R&D processes and improve success rates. AI's ability to analyze vast datasets and generate insights is proving invaluable in the quest for novel therapeutics and personalized treatment options.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Component
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Deployment
  • 2.8 Key Market Highlights by Solutions
  • 2.9 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Machine Learning
    • 4.1.2 Natural Language Processing
    • 4.1.3 Computer Vision
    • 4.1.4 Robotics
    • 4.1.5 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 AI-based Software
    • 4.2.2 AI-based Hardware
    • 4.2.3 AI-based Services
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Deep Learning
    • 4.3.2 Predictive Analytics
    • 4.3.3 Speech Recognition
    • 4.3.4 Image Recognition
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by Component (2020-2035)
    • 4.4.1 Software
    • 4.4.2 Hardware
    • 4.4.3 Services
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Clinical Trials
    • 4.5.2 Robot-Assisted Surgery
    • 4.5.3 Virtual Nursing Assistants
    • 4.5.4 Administrative Workflow Assistance
    • 4.5.5 Fraud Detection
    • 4.5.6 Diagnosis and Treatment
    • 4.5.7 Patient Management
    • 4.5.8 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Pharmaceutical Companies
    • 4.6.3 Research Laboratories
    • 4.6.4 Healthcare Providers
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Deployment (2020-2035)
    • 4.7.1 Cloud-Based
    • 4.7.2 On-Premises
    • 4.7.3 Hybrid
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Solutions (2020-2035)
    • 4.8.1 Patient Data & Risk Analytics
    • 4.8.2 Medical Imaging & Diagnostics
    • 4.8.3 Lifestyle Management & Monitoring
    • 4.8.4 Virtual Assistants
    • 4.8.5 Others
  • 4.9 Market Size & Forecast by Mode (2020-2035)
    • 4.9.1 B2B
    • 4.9.2 B2C
    • 4.9.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Component
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Deployment
      • 5.2.1.8 Solutions
      • 5.2.1.9 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Component
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Deployment
      • 5.2.2.8 Solutions
      • 5.2.2.9 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Component
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Deployment
      • 5.2.3.8 Solutions
      • 5.2.3.9 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Component
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Deployment
      • 5.3.1.8 Solutions
      • 5.3.1.9 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Component
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Deployment
      • 5.3.2.8 Solutions
      • 5.3.2.9 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Component
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Deployment
      • 5.3.3.8 Solutions
      • 5.3.3.9 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Component
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Deployment
      • 5.4.1.8 Solutions
      • 5.4.1.9 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Component
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Deployment
      • 5.4.2.8 Solutions
      • 5.4.2.9 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Component
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Deployment
      • 5.4.3.8 Solutions
      • 5.4.3.9 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Component
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Deployment
      • 5.4.4.8 Solutions
      • 5.4.4.9 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Component
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Deployment
      • 5.4.5.8 Solutions
      • 5.4.5.9 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Component
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Deployment
      • 5.4.6.8 Solutions
      • 5.4.6.9 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Component
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Deployment
      • 5.4.7.8 Solutions
      • 5.4.7.9 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Component
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Deployment
      • 5.5.1.8 Solutions
      • 5.5.1.9 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Component
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Deployment
      • 5.5.2.8 Solutions
      • 5.5.2.9 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Component
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Deployment
      • 5.5.3.8 Solutions
      • 5.5.3.9 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Component
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Deployment
      • 5.5.4.8 Solutions
      • 5.5.4.9 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Component
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Deployment
      • 5.5.5.8 Solutions
      • 5.5.5.9 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Component
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Deployment
      • 5.5.6.8 Solutions
      • 5.5.6.9 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Component
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Deployment
      • 5.6.1.8 Solutions
      • 5.6.1.9 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Component
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Deployment
      • 5.6.2.8 Solutions
      • 5.6.2.9 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Component
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Deployment
      • 5.6.3.8 Solutions
      • 5.6.3.9 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Component
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Deployment
      • 5.6.4.8 Solutions
      • 5.6.4.9 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Component
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Deployment
      • 5.6.5.8 Solutions
      • 5.6.5.9 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 IBM
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Microsoft
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Google
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Amazon
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Siemens Healthineers
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Philips Healthcare
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 GE Healthcare
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Medtronic
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Cerner Corporation
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Epic Systems Corporation
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 NVIDIA
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Intel Corporation
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Nuance Communications
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Allscripts Healthcare Solutions
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Zebra Medical Vision
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 iCarbonX
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Tempus Labs
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 PathAI
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Butterfly Network
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Viz.ai
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us